Funding Round
Rune Labs closes $30M Series B for Parkinson's disease digital biomarker platform
Rock Health Newsletter4/8/2026·04/08/26🌐 USA
Summary
San Francisco-based Rune Labs raised a $30M Series B led by SoftBank Vision Fund 2, with Andreessen Horowitz and Ajax Health. The company's StrivePD Parkinson's monitoring platform now serves 8,000 patients and is integrated with Medtronic Percept DBS, Apple Watch, and Kinesia motion sensing. Funds support EU expansion and new indication pilots.
Why it matters
SoftBank Vision Fund leading a neurotech digital health Series B is a significant signal. Rune's integration with Medtronic Percept — the first commercial LFP-sensing DBS — positions them as the data layer for the adaptive DBS ecosystem as it commercializes.
#AI Diagnostics#Biomarkers#Industry#Parkinson's#USA#Venture Capital#Wearables
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in